Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021

SELL
$5.03 - $8.8 $4.27 Million - $7.48 Million
-849,588 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$4.78 - $8.26 $1.17 Million - $2.03 Million
245,797 Added 40.71%
849,588 $5.88 Million
Q1 2020

May 14, 2020

BUY
$4.0 - $21.53 $782,684 - $4.21 Million
195,671 Added 47.94%
603,791 $2.42 Million
Q4 2019

Feb 13, 2020

BUY
$13.94 - $24.12 $1.67 Million - $2.88 Million
119,563 Added 41.43%
408,120 $8.75 Million
Q3 2019

Nov 13, 2019

SELL
$13.89 - $23.16 $3.68 Million - $6.13 Million
-264,738 Reduced 47.85%
288,557 $4.38 Million
Q2 2019

Aug 14, 2019

SELL
$16.27 - $20.51 $944,587 - $1.19 Million
-58,057 Reduced 9.5%
553,295 $10.7 Million
Q1 2019

May 14, 2019

SELL
$12.61 - $22.33 $538,447 - $953,490
-42,700 Reduced 6.53%
611,352 $12.7 Million
Q4 2018

Feb 13, 2019

SELL
$12.41 - $22.98 $1.24 Million - $2.3 Million
-99,997 Reduced 13.26%
654,052 $8.9 Million
Q3 2018

Nov 13, 2018

BUY
$2.45 - $16.27 $675,955 - $4.49 Million
275,900 Added 57.7%
754,049 $12.3 Million
Q1 2018

May 14, 2018

SELL
$2.99 - $4.44 $1.43 Million - $2.12 Million
-478,151 Reduced 50.0%
478,149 $1.44 Million
Q3 2017

Nov 13, 2017

BUY
$3.03 - $3.72 $2.9 Million - $3.56 Million
956,300
956,300 $3.35 Million

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $6.59B
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Tekla Capital Management LLC Portfolio

Follow Tekla Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tekla Capital Management LLC with notifications on news.